Back to search

Article

Therapeutically targeting the classical complement pathway with antisense oligonucleotides in Alzheimer’s disease

2024-08-26

Abstract excerpt

The complement classical pathway (CP) is a key mediator of synapse loss and neurodegeneration in mouse models of Alzheimer’s (AD) and other neurodegenerative diseases. We analyzed human brain proteomics and found consistent elevations of all CP proteins, but not other complement pathways, in AD patient brains. We performed human genetics analysis that identified a rare variant in the C1S gene within the Finnish p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
130e72ae-6204-513c-891b-c758d4f64f93
DOI
10.1101/2024.08.23.609240
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapeutically targeting the classical complement pathway with antisense oligonucleotides in Alzheimer’s diseaseDOI 10.1101/2024.08.23.609240
Select a neighboring publication to make it the new centre.